Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: J Invest Dermatol. 2012 Mar 8;132(6):1689–1697. doi: 10.1038/jid.2012.36

Table 1. Methylation Status of AIM1_Promoter Region in Melanoma Tissue.

AJCC stage Hypermethylation
Normal Tissue Total (n=26) 0 (0%)
Skin (n=14) 0 (0%)
Nevi (n=12) 0 (0%)

Primary Melanoma Total (n=58) 22 (38%)
Stage I (n=14) 4 (29%)
Stage II (n=14) 8 (57%)
Stage III Primary Tumor (m=30) 10 (33%)

Metastasis Tumor Total (n=54) 35 (65%)
Stage III Nodal Metastasis (n=23) 11 (48%)
Stage IV (n=31) 24 (77%)
HHS Vulnerability Disclosure